Selleck Chemicals FDA-approved Anticancer Drug Library

Friday, 04 April, 2025 | Supplied by: Sapphire Bioscience


Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential anticancer activity, suitable for use in high-throughput screening (HTS) and high-content screening (HCS). All drugs are from approved institutions such as the FDA, EMA, HMA, CFDA and PMDA, or pharmacopoeia such as USP, BP, EP, JP, etc.

With bioactivity and safety confirmed by clinical trials, the drug library is structurally diverse, medicinally active and cell permeable. It has been cited in over 300 publications, with rich documentation with structure and customer reviews, and has been NMR and HPLC validated for high purity.

The library consists of 1559 compounds pre-dissolved in 10 mM DMSO, 112 compounds pre-dissolved in 10 mM water, 54 compounds pre-dissolved in 2 mM DMSO and nine compounds pre-dissolved in 2 mM water. Each library is supplied in a 96 deep well plate format sealed with aluminium foil. The DMSO-dissolved compounds are stable for 12 months at -20°C or 24 months at -80°C.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Biosynth carbohydrates

Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...

Cayman Chemical Stem Cell Small Molecule Screening Library

The screening library contains more than 140 small molecules that are known either to induce...

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd